Bpifrance Le Hub Highlights Elkedonia’s Mission to Revolutionize Psychiatry

Elkedonia is featured by Bpifrance Le Hub for its commitment to developing rapid-acting, home-administered antidepressants without side effects for patients with treatment-resistant depression. By reintegrating biology into neuropsychiatry, the company aims to provide urgent new therapeutic options in a field that has lacked major innovation for decades.